复旦大学附属中山医院心内科副主任，导管室副主任，结构性心脏病、肺动脉高压专科主任，博士研究生导师。

中华医学会心血管病专委会委员，中国医师协会心血管病分会结构性心脏病专委会副主任委员、中华医学会心电生理分会左心耳封堵工作委员会副主任委员、上海市心血管病学会结构性心脏病学组副组长、东方心脏病学大会结构论坛坛主、中国医师学会肺动脉高压规范化治疗基地主任、卫计委先天性心脏病介入治疗培训基地主任、长三角心源性卒中防治专委会主任委员、《中国临床药学杂志》常务编委、《中国介入心脏病学杂志》编委、《中华心血管病杂志》网络版编委、《上海医药杂志》编委

起草《导管主动脉瓣置换专家共识》、《经导管主动脉瓣置换团队建设》、《中国左心耳封堵治疗临床路径》专家共识，参加制订中国结构心脏病诊疗指南，起草房间隔介入治疗专家共识，参加制定中国肺动脉高压诊疗指南，参加制定中国先天心脏病合并重度肺动脉高压治疗专家共识。卫计委心血管病介入治疗考试命题专家。

《结构性心脏病介入诊疗病例解析》、《经导管心脏瓣膜治疗术》、《肺动脉高压治疗学》主编，《疑难先天性心脏病介入治疗与图解》副主编。

以第一完成人获得上海市科委课题3项，其中重点课题一项。

《产学研》课题三项，获得专利10项，其中发明专利2项，事项专利转化3项。

在国内、外期刊专业刊物上以第一作者名义发表论文近400余篇论文，被SCI收录近60余篇。

2014年以第一完成人获得上海市科技进步三等奖。

2021荣获教育部科技进步一等奖。

• Deputy Director of the Department of Cardiology and Deputy Director of the Catheterization Laboratory at Zhongshan Hospital, Fudan University; Director of the Structural Heart Disease and Pulmonary Hypertension Program; Doctoral Supervisor.

• Member of the Cardiovascular Disease Committee and Vice Chair of the Left Atrial Appendage Occlusion Working Committee of the Chinese Society of Pacing and Electrophysiology, Chinese Medical Association; Vice Chair of the Structural Heart Disease Committee of the Chinese Society of Cardiovascular Diseases and Director of the Standardized Treatment Center for Pulmonary Hypertension, Chinese Medical Doctor Association; Deputy Leader of the Structural Heart Disease Group of the Shanghai Society of Cardiovascular Diseases; Chair of the Structural Heart Disease Forum of the Oriental Congress of Cardiology; Director of the Training Base for Interventional Therapy of Congenital Heart Disease, National Health Commision of China; Chair of the Yangtze River Delta Committee for the Prevention and Treatment of Cardioembolic Stroke. 

• Executive Editorial Board Member of the Chinese Journal of Clinical Pharmacy; and Editorial Board Member of the Chinese Journal of Interventional Cardiology, Chinese Journal of Cardiology (online edition), and Shanghai Medical & Pharmaceutical Journal

• Participated in drafting the “Expert Consensus on Transcatheter Aortic Valve Replacement,” “Team Development for Transcatheter Aortic Valve Replacement,” and the “China Clinical Pathway for Left Atrial Appendage Closure”;  as well as the Chinese Guidelines for the Diagnosis and Treatment of Structural Heart Disease; the Expert Consensus on Interventional Treatment of Atrial Septal Defects; Chinese Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension, and the Expert Consensus on the Management of Congenital Heart Disease with Severe Pulmonary Hypertension. N

• Serves as an question development expert for the Cardiovascular Interventional Therapy Accreditation Examination under the National Health Commission.

• Chief editor of Case Analyses of Intervention of Structural Heart Diseases, Transcatheter Heart Valve Therapy, and Therapeutics of Pulmonary Hypertension; deputy chief editor of Atlas of Interventional Therapy for Miscellaneous Congenital Heart Disease.

• Obtained three research grants from the Shanghai Science and Technology Commission as first principal investigator, including one key project.

• Led three industry–academia–research projects; holds ten patents, including two invention patents, with three patents successfully translated.

• First author of over 400 papers in Chinese and international journals, with more than SCI-indexed 60 papers.

• Recipient of the Shanghai Science and Technology Progress Award (Third Prize) in 2014 as the principal investigator, and the Ministry of Education Science and Technology Progress Award (First Prize) in 2021.